Nordson Corp Files 8-K on Other Events and Financials

TL;DR

Nordson filed an 8-K on 5/28 detailing corporate events and financials.

AI Summary

Nordson Corporation filed an 8-K on May 28, 2024, to report other events and financial statements. The filing details Nordson's principal executive offices located at 28601 Clemens Road, Westlake, Ohio, 44145, and its primary business in general industrial machinery and equipment.

Why It Matters

This filing provides an update on Nordson Corporation's corporate activities and financial reporting, which is important for investors and stakeholders to stay informed about the company's status.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, which typically reports on significant corporate events or financial updates without indicating immediate financial distress or major operational changes.

Key Numbers

• 000-07977 — Commission File Number (Identifies Nordson Corp's SEC filing history.)
• 34-0590250 — I.R.S. Employer Identification Number (Nordson Corp's tax identification number.)

Key Players & Entities

• NORDSON CORP (company) — Registrant
• Ohio (location) — State of Incorporation
• 28601 Clemens Road (address) — Principal Executive Offices
• Westlake (location) — City of Principal Executive Offices
• 44145 (zip_code) — Zip Code of Principal Executive Offices
• 440-892-1580 (phone_number) — Registrant's Telephone Number

FAQ

Filing Documents

• d836379d8k.htm (8-K) — 42KB
• d836379dex991.htm (EX-99.1) — 29KB
• d836379dex992.htm (EX-99.2) — 25KB
• g836379ex99_2s10g1.jpg (GRAPHIC) — 21KB
• g836379ex99_2s11g1.jpg (GRAPHIC) — 184KB
• g836379ex99_2s12g1.jpg (GRAPHIC) — 86KB
• g836379ex99_2s1g1.jpg (GRAPHIC) — 96KB
• g836379ex99_2s2g1.jpg (GRAPHIC) — 76KB
• g836379ex99_2s3g1.jpg (GRAPHIC) — 235KB
• g836379ex99_2s4g1.jpg (GRAPHIC) — 112KB
• g836379ex99_2s5g1.jpg (GRAPHIC) — 105KB
• g836379ex99_2s6g1.jpg (GRAPHIC) — 104KB
• g836379ex99_2s7g1.jpg (GRAPHIC) — 116KB
• g836379ex99_2s8g1.jpg (GRAPHIC) — 117KB
• g836379ex99_2s9g1.jpg (GRAPHIC) — 97KB
• 0001193125-24-147674.txt ( ) — 2105KB
• ndsn-20240528.xsd (EX-101.SCH) — 3KB
• ndsn-20240528_lab.xml (EX-101.LAB) — 18KB
• ndsn-20240528_pre.xml (EX-101.PRE) — 11KB
• d836379d8k_htm.xml (XML) — 4KB

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. 99.1 Press release of Nordson Corporation dated May 28, 2024. 99.2 Investor Presentation dated May 28, 2024. 104 Cover Page Interactive Data File (embedded within the inline XBRL document). Additional Information and Where to Find It Atrion Corporation ("Atrion") expects to file with the Securities and Exchange Commission ("SEC") and furnish to its stockholders a proxy statement on Schedule 14A (the "Proxy Statement"), as well as other relevant documents regarding the transactions contemplated by the Agreement and Plan of Merger (the "Agreement"), dated as of May 28, 2024, by and among Atrion, Nordson Corporation ("Nordson"), and Alpha Medical Merger Sub, Inc. (the "Transaction"). The information to be included in the preliminary Proxy Statement will not be complete and may be changed. After filing its definitive Proxy Statement with the SEC, Atrion will mail its definitive Proxy Statement and a proxy card to Atrion's stockholders entitled to vote at a special meeting relating to the Transaction, seeking their approval of the applicable Transaction-related proposals. The Proxy Statement will contain important information about the Transaction and related matters. This communication is not a substitute for the Proxy Statement Atrion plans to file with the SEC in connection with the Transaction. INVESTORS AND SECURITY HOLDERS OF ATRION ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THE PROXY STATEMENT WHEN IT BECOMES AVAILABLE, AS WELL AS OTHER RELEVANT DOCUMENTS FILED WITH THE SEC IN CONNECTION WITH THE TRANSACTION OR INCORPORATED BY REFERENCE INTO THE PROXY STATEMENT, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO SUCH DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT ATRION, NORDSON, THE TRANSACTION AND THE OTHER TRANSACTIONS CONTEMPLATED BY THE AGREEMENT THAT HOLDERS OF ATRION'S SECURITIES SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING VOTING. Investors and security holders

Forward-Looking Statements

Forward-Looking Statements This communication contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements present current forecasts and estimates of future events. These statements do not strictly relate to historical or current results and can be identified by words such as "anticipate," "appear," "assume," "believe," "estimate," "expect," "forecast," "intend," "likely," "may," "plan," "project," "seek," "should," "strategy," "will," "can," "could," "predict," "future," "potential," "look," "build," "focus," "create," "work," "continue," "target," "poised," "advance," "drive," "aim," "approach," "seek," "schedule," "position," "pursue," "progress," "budget," "outlook," "trend," "guidance," "commit," "on track," "objective," "goal," "opportunity," "ambitions," "aspire" and variations of negatives of such terms or variations thereof. Other words and terms of similar meaning or import in connection with any discussion of future plans, actions, events or operating, financial or other performance identify forward-looking statements. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements regarding the Agreement and the Transaction, including the expected time period to consummate the Transaction, the anticipated benefits (including synergies) of the Transaction and integration and transition plans, opportunities, anticipated future performance, expected share buyback programs and expected dividends. All such forward-looking statements are based upon current plans, estimates, expectations and ambitions that are subject to risks, uncertainties, assumptions and other factors, many of which are beyond the control of Atrion and Nordson, that could cause actual results to differ materially from the results projected in such forward-looking statements. These risks, uncertainties, assumpti

View Full Filing

View this 8-K filing on SEC EDGAR